{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T21:19:17Z","timestamp":1794863957715,"version":"4.9.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,19]],"date-time":"2022-12-19T00:00:00Z","timestamp":1671408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,19]],"date-time":"2022-12-19T00:00:00Z","timestamp":1671408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    This study was conducted to investigate the relationship between serum endothelial dysfunction-related biomarker levels and organ dysfunction severity in septic patients and the predictive value of these levels during sepsis. In total, 105 patients admitted to the Department of Critical Care Medicine were enrolled between September 2020 and November 2021. Serum syndecan-1 and soluble thrombomodulin(sTM) levels were measured by enzyme-linked immunosorbent assay, and clinical and laboratory data were recorded. Enroll patients were divided into the infection (n\u2009=\u200928), septic nonshock (n\u2009=\u200931), and septic shock (n\u2009=\u200946) groups . Serum syndecan-1 (102.84\u2009\u00b1\u200916.53 vs. 55.38\u2009\u00b1\u200912.34\u00a0ng\/ml), and sTM(6.60\u2009\u00b1\u20091.44\u00a0ng\/ml vs. 5.23\u2009\u00b1\u20091.23\u00a0ng\/ml, P\u2009&lt;\u20090.01) levels were increased in the septic group compared with those in the infection group. Serum syndecan-1 levels were closely positively correlated with serum sTM (r\n                    <jats:sub>s<\/jats:sub>\n                    \u2009=\u20090.712, r\n                    <jats:sup>2<\/jats:sup>\n                    \u2009=\u20090.507, P\u2009&lt;\u20090.001). Additionally, serum syndecan-1(r\n                    <jats:sub>s<\/jats:sub>\n                    \u2009=\u20090.687, r\n                    <jats:sup>2<\/jats:sup>\n                    \u2009=\u20090.472, P\u2009&lt;\u20090.001) and sTM levels (r\n                    <jats:sub>s<\/jats:sub>\n                    \u2009=\u20090.6, r\n                    <jats:sup>2<\/jats:sup>\n                    \u2009=\u20090.36, P\u2009&lt;\u20090.01) levels were significantly positively correlated with the sequential organ failure assessment scores respectively. Syndecan-1 (AUC 0.95\u2009\u00b1\u20090.02, P\u2009&lt;\u20090.0001) was more valuable for prediction sepsis than was sTM (AUC 0.87\u2009\u00b1\u20090.04, P\u2009&lt;\u20090.0001). Compared with sTM (AUC 0.88\u2009\u00b1\u20090.03, P\u2009&lt;\u20090.001), syndecan-1 (AUC 0.95\u2009\u00b1\u20090.02, P\u2009&lt;\u20090.001) and SOFA score (AUC 0.95\u2009\u00b1\u20090.02, P\u2009&lt;\u20090.001) were better predictors of septic shock. Serum syndecan-1 and sTM levels were associated with organ dysfunction severity in septic patients, and both were good predictors for early identification of sepsis, particularly in patients undergoing septic shock.\n                  <\/jats:p>","DOI":"10.1038\/s41598-022-26623-y","type":"journal-article","created":{"date-parts":[[2022,12,19]],"date-time":"2022-12-19T09:03:25Z","timestamp":1671440605000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Elevated endothelial dysfunction-related biomarker levels indicate the severity and predict sepsis incidence"],"prefix":"10.1038","volume":"12","author":[{"given":"Gaosheng","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,19]]},"reference":[{"issue":"8","key":"26623_CR1","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer, M. et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315(8), 801\u2013810 (2016).","journal-title":"JAMA"},{"issue":"3","key":"26623_CR2","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/SHK.0000000000000473","volume":"45","author":"C Ince","year":"2016","unstructured":"Ince, C. et al. The endothelium in sepsis. Shock 45(3), 259\u2013270 (2016).","journal-title":"Shock"},{"issue":"3","key":"26623_CR3","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1164\/rccm.201910-1911TR","volume":"202","author":"J Joffre","year":"2020","unstructured":"Joffre, J., Hellman, J., Ince, C. & Ait-Oufella, H. Endothelial responses in sepsis. Am. J. Respir. Crit. Care Med. 202(3), 361\u2013370 (2020).","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"26623_CR4","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13054-018-2292-6","volume":"23","author":"R Uchimido","year":"2019","unstructured":"Uchimido, R., Schmidt, E. P. & Shapiro, N. I. The glycocalyx: A novel diagnostic and therapeutic target in sepsis. Crit. Care 23(1), 16 (2019).","journal-title":"Crit. Care"},{"issue":"4","key":"26623_CR5","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.ajpath.2019.11.016","volume":"190","author":"S Dogn\u00e9","year":"2020","unstructured":"Dogn\u00e9, S. & Flamion, B. Endothelial glycocalyx impairment in disease: Focus on hyaluronan shedding. Am. J. Pathol. 190(4), 768\u2013780 (2020).","journal-title":"Am. J. Pathol."},{"key":"26623_CR6","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jcrc.2017.07.049","volume":"43","author":"M Ikeda","year":"2018","unstructured":"Ikeda, M. et al. Circulating syndecan-1 predicts the development of disseminated intravascular coagulation in patients with sepsis. J. Crit. Care 43, 48\u201353 (2018).","journal-title":"J. Crit. Care"},{"key":"26623_CR7","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jcrc.2018.06.015","volume":"47","author":"L Smart","year":"2018","unstructured":"Smart, L. et al. Glycocalyx biomarker syndecan-1 is a stronger predictor of respiratory failure in patients with sepsis due to pneumonia, compared to endocan. J. Crit. Care 47, 93\u201398 (2018).","journal-title":"J. Crit. Care"},{"issue":"6","key":"26623_CR8","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1097\/SHK.0b013e3181777da3","volume":"30","author":"A Nelson","year":"2008","unstructured":"Nelson, A., Berkestedt, I., Schmidtchen, A., Ljunggren, L. & Bodelsson, M. Increased levels of glycosaminoglycans during septic shock: Relation to mortality and the antibacterial actions of plasma. Shock 30(6), 623\u2013627 (2008).","journal-title":"Shock"},{"issue":"3","key":"26623_CR9","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1111\/j.1399-6576.2011.02578.x","volume":"56","author":"M Sallisalmi","year":"2012","unstructured":"Sallisalmi, M., Tenhunen, J., Yang, R., Oksala, N. & Pettil\u00e4, V. Vascular adhesion protein-1 and syndecan-1 in septic shock. Acta Anaesthesiol. Scand. 56(3), 316\u2013322 (2012).","journal-title":"Acta Anaesthesiol. Scand."},{"issue":"9","key":"26623_CR10","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1111\/liv.13087","volume":"36","author":"V La Mura","year":"2016","unstructured":"La Mura, V. et al. Resistance to thrombomodulin is associated with de novo portal vein thrombosis and low survival in patients with cirrhosis. Liver Int. 36(9), 1322\u20131330 (2016).","journal-title":"Liver Int."},{"key":"26623_CR11","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.3389\/fimmu.2019.02535","volume":"10","author":"B Shrestha","year":"2019","unstructured":"Shrestha, B. et al. Recombinant thrombomodulin suppresses histone-induced neutrophil extracellular trap formation. Front. Immunol. 10, 2535 (2019).","journal-title":"Front. Immunol."},{"issue":"5","key":"26623_CR12","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1055\/s-0038-1648199","volume":"65","author":"H Ishii","year":"1991","unstructured":"Ishii, H., Uchiyama, H. & Kazama, M. Soluble thrombomodulin antigen in conditioned medium is increased by damage of endothelial cells. Thromb. Haemost. 65(5), 618\u2013623 (1991).","journal-title":"Thromb. Haemost."},{"issue":"5","key":"26623_CR13","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1097\/SHK.0b013e318157e926","volume":"29","author":"X Marechal","year":"2008","unstructured":"Marechal, X. et al. Endothelial glycocalyx damage during endotoxemia coincides with microcirculatory dysfunction and vascular oxidative stress. Shock 29(5), 572\u2013576 (2008).","journal-title":"Shock"},{"issue":"2","key":"26623_CR14","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1097\/TA.0b013e31821e0f93","volume":"72","author":"PI Johansson","year":"2012","unstructured":"Johansson, P. I., Stensballe, J., Rasmussen, L. S. & Ostrowski, S. R. High circulating adrenaline levels at admission predict increased mortality after trauma. J. Trauma Acute Care Surg. 72(2), 428\u2013436 (2012).","journal-title":"J. Trauma Acute Care Surg."},{"issue":"1","key":"26623_CR15","doi-asserted-by":"publisher","first-page":"R32","DOI":"10.1186\/cc12532","volume":"17","author":"SR Ostrowski","year":"2013","unstructured":"Ostrowski, S. R., Pedersen, S. H., Jensen, J. S., Mogelvang, R. & Johansson, P. I. Acute myocardial infarction is associated with endothelial glycocalyx and cell damage and a parallel increase in circulating catecholamines. Crit. Care 17(1), R32 (2013).","journal-title":"Crit. Care"},{"issue":"2","key":"26623_CR16","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.ccc.2019.12.001","volume":"36","author":"S Pons","year":"2020","unstructured":"Pons, S. et al. Immune consequences of endothelial cells\u2019 activation and dysfunction during sepsis. Crit. Care Clin. 36(2), 401\u2013413 (2020).","journal-title":"Crit. Care Clin."},{"issue":"1","key":"26623_CR17","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1055\/s-0034-1398377","volume":"41","author":"ME Johansen","year":"2015","unstructured":"Johansen, M. E. et al. Profound endothelial damage predicts impending organ failure and death in sepsis. Semin. Thromb. Hemost. 41(1), 16\u201325 (2015).","journal-title":"Semin. Thromb. Hemost."},{"issue":"10\u201311","key":"26623_CR18","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.clinbiochem.2016.02.014","volume":"49","author":"D Anand","year":"2016","unstructured":"Anand, D., Ray, S., Srivastava, L. M. & Bhargava, S. Evolution of serum hyaluronan and syndecan levels in prognosis of sepsis patients. Clin. Biochem. 49(10\u201311), 768\u2013776 (2016).","journal-title":"Clin. Biochem."},{"issue":"5","key":"26623_CR19","doi-asserted-by":"publisher","first-page":"5561","DOI":"10.21037\/apm-21-1048","volume":"10","author":"L Yue","year":"2021","unstructured":"Yue, L., Deng, X., Yang, M. & Li, X. Elevated B-type natriuretic peptide (BNP) and soluble thrombomodulin (sTM) indicates severity and poor prognosis of sepsis. Ann. Palliat. Med. 10(5), 5561\u20135567 (2021).","journal-title":"Ann. Palliat. Med."},{"issue":"1","key":"26623_CR20","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s13054-021-03545-1","volume":"25","author":"A Piotti","year":"2021","unstructured":"Piotti, A. et al. Endothelial damage in septic shock patients as evidenced by circulating syndecan-1, sphingosine-1-phosphate and soluble VE-cadherin: A substudy of ALBIOS. Crit. Care 25(1), 113 (2021).","journal-title":"Crit. Care"},{"issue":"11","key":"26623_CR21","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1177\/0885066620949131","volume":"36","author":"X Huang","year":"2021","unstructured":"Huang, X. et al. Plasma endothelial glycocalyx components as a potential biomarker for predicting the development of disseminated intravascular coagulation in patients with sepsis. J. Intensive Care Med. 36(11), 1286\u20131295 (2021).","journal-title":"J. Intensive Care Med."},{"key":"26623_CR22","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ajem.2021.01.019","volume":"42","author":"J Saoraya","year":"2021","unstructured":"Saoraya, J., Wongsamita, L., Srisawat, N. & Musikatavorn, K. Plasma syndecan-1 is associated with fluid requirements and clinical outcomes in emergency department patients with sepsis. Am. J. Emerg. Med. 42, 83\u201389 (2021).","journal-title":"Am. J. Emerg. Med."},{"key":"26623_CR23","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s13054-015-0918-5","volume":"19","author":"SR Ostrowski","year":"2015","unstructured":"Ostrowski, S. R. et al. Association between biomarkers of endothelial injury and hypocoagulability in patients with severe sepsis: A prospective study. Crit. Care 19, 191 (2015).","journal-title":"Crit. Care"},{"key":"26623_CR24","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13054-017-1605-5","volume":"21","author":"PI Johansson","year":"2017","unstructured":"Johansson, P. I., Stensballe, J. & Ostrowski, S. R. Shock induced endotheliopathy (SHINE) in acute critical illness: A unifying pathophysiologic mechanism. Crit. Care 21, 25 (2017).","journal-title":"Crit. Care"},{"issue":"2 Suppl","key":"26623_CR25","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.1097\/CCM.0b013e3181c98d21","volume":"38","author":"M Levi","year":"2010","unstructured":"Levi, M. & van der Poll, T. Inflammation and coagulation. Crit. Care Med. 38(2 Suppl), S26-34 (2010).","journal-title":"Crit. Care Med."},{"key":"26623_CR26","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1089\/ars.2021.0027","volume":"35","author":"J Joffre","year":"2021","unstructured":"Joffre, J. & Hellman, J. Oxidative stress and endothelial dysfunction in sepsis and acute inflammation. Antioxid. Redox Signal. 35, 1291\u20131307 (2021).","journal-title":"Antioxid. Redox Signal."},{"issue":"4","key":"26623_CR27","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.ymgme.2012.01.016","volume":"105","author":"AW El-Hattab","year":"2012","unstructured":"El-Hattab, A. W. et al. Restoration of impaired nitric oxide production in MELAS syndrome with citrulline and arginine supplementation. Mol. Genet. Metab. 105(4), 607\u2013614 (2012).","journal-title":"Mol. Genet. Metab."},{"key":"26623_CR28","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12916-015-0365-9","volume":"13","author":"J Hanson","year":"2015","unstructured":"Hanson, J. et al. Microvascular obstruction and endothelial activation are independently associated with the clinical manifestations of severe falciparum malaria in adults: An observational study. BMC Med. 13, 122 (2015).","journal-title":"BMC Med."},{"key":"26623_CR29","doi-asserted-by":"publisher","first-page":"10414","DOI":"10.1038\/s41598-022-14365-w","volume":"12","author":"J Liu","year":"2022","unstructured":"Liu, J. et al. Mitochondrial Sirt3 serves as a biomarker for sepsis diagnosis and mortality prediction. Sci. Rep. 12, 10414 (2022).","journal-title":"Sci. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-26623-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-26623-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-26623-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,19]],"date-time":"2022-12-19T09:05:46Z","timestamp":1671440746000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-26623-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,19]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["26623"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-26623-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,19]]},"assertion":[{"value":"28 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21935"}}